TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07675408: Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease

Sponsor: Fortis Medical Devices Limited · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 60 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,280,400

Rescue Site Savings

+$853,600

Unlock Full NCT07675408 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07675408 Rescue Dossier →